Skip to content

Use of cardiac markers to assess the toxic effects of anthracyclines given to children with cancer: a systematic review

Research output: Contribution to journalReview articlepeer-review

  • Jackie Bryant
  • J Picot
  • L Baxter
  • G Levitt
  • I Sullivan
  • A Clegg

AIM: To evaluate the effectiveness of cardiac markers to quantify anthracycline-induced cardiotoxicity in children with cancer.

METHODS: Systematic review using a priori methods.

RESULTS: Seven studies, all with methodological limitations, were identified. One RCT suggests that cardiac troponin can be used to assess the effectiveness of the cardio-protective agent dexrazoxane. Cohort studies suggest that atrial natriuretic peptide and brain (B-type) natriuretic peptide are elevated in some subgroups of patients compared with healthy children; NT-pro-BNP levels are significantly elevated in children with cardiac dysfunction compared with those without; serum lipid peroxide is higher in children who have received doxorubicin compared with children not receiving doxorubicin; there are no differences in carnitine levels between children treated with doxorubicin and a healthy control group.

CONCLUSIONS: The limited evidence makes conclusions difficult. Research is needed to fill this important evidence gap and link short-term changes in cardiac markers to longer-term cardiac damage.

Original languageEnglish
Pages (from-to)1959-66
Number of pages8
JournalEuropean Journal Of Cancer Care
Issue number13
Publication statusPublished - Sep 2007

Related information

Relations Get citation (various referencing formats)

ID: 10214389